| Adopt a moratorium on heritable genome editing ES Lander, F Baylis, F Zhang, E Charpentier, P Berg, C Bourgain, ... Nature 567 (7747), 165-168, 2019 | 571 | 2019 |
| Moral residue GC Webster, FE Baylis | 381 | 2000 |
| Crossing species boundaries JS Robert, F Baylis American Journal of Bioethics 3 (3), 1-13, 2003 | 366 | 2003 |
| A relational account of public health ethics F Baylis, NP Kenny, S Sherwin Public health ethics 1 (3), 196-209, 2008 | 335 | 2008 |
| “I am who I am”: On the perceived threats to personal identity from deep brain stimulation F Baylis Neuroethics 6, 513-526, 2013 | 219 | 2013 |
| The inevitability of genetic enhancement technologies F Baylis, JS Robert Bioethics 18 (1), 1-26, 2004 | 199 | 2004 |
| The ethics of creating children with three genetic parents F Baylis Reproductive biomedicine online 26 (6), 531-534, 2013 | 178 | 2013 |
| Altered inheritance: CRISPR and the ethics of human genome editing F Baylis Harvard University Press, 2019 | 167 | 2019 |
| Social egg freezing: risk, benefits and other considerations A Petropanagos, A Cattapan, F Baylis, A Leader Cmaj 187 (9), 666-669, 2015 | 151 | 2015 |
| Target populations for first-in-human embryonic stem cell research in spinal cord injury F Bretzner, F Gilbert, F Baylis, RM Brownstone Cell stem cell 8 (5), 468-475, 2011 | 150 | 2011 |
| Knowledge and attitudes of pregnant women with regard to collection, testing and banking of cord blood stem cells CV Fernandez, K Gordon, M Van den Hof, S Taweel, F Baylis CMAJ 168 (6), 695-698, 2003 | 148 | 2003 |
| Ten reasons why immunity passports are a bad idea N Kofler, F Baylis Nature 581 (7809), 379-381, 2020 | 139 | 2020 |
| First-in-human phase 1 CRISPR gene editing cancer trials: are we ready? F Baylis, M McLeod Current gene therapy 17 (4), 309-319, 2017 | 132 | 2017 |
| Dancing with the porcupine: rules for governing the university–industry relationship S Lewis, P Baird, RG Evans, WA Ghali, CJ Wright, E Gibson, F Baylis Cmaj 165 (6), 783-785, 2001 | 129 | 2001 |
| Human germline and heritable genome editing: the global policy landscape F Baylis, M Darnovsky, K Hasson, TM Krahn The CRISPR Journal 3 (5), 365-377, 2020 | 127 | 2020 |
| Re-visioning public health ethics: A relational perspective NP Kenny, SB Sherwin, FE Baylis Canadian journal of public health 101 (1), 9-11, 2010 | 112 | 2010 |
| The ethical physician encounters international medical travel GKD Crozier, F Baylis Journal of Medical Ethics 36 (5), 297-301, 2010 | 110 | 2010 |
| Pregnant women deserve better F Baylis Nature 465 (7299), 689-690, 2010 | 104 | 2010 |
| Geneva statement on heritable human genome editing: the need for course correction R Andorno, F Baylis, M Darnovsky, D Dickenson, H Haker, K Hasson, ... Trends in biotechnology 38 (4), 351-354, 2020 | 89 | 2020 |
| The stem cell debate continues: the buying and selling of eggs for research F Baylis, C McLeod Journal of Medical Ethics 33 (12), 726-731, 2007 | 83 | 2007 |
Alana CattapanUniversity of WaterlooEmail yang diverifikasi di uwaterloo.ca